Literature DB >> 2610695

Visualization of interleukin-2-like molecules in MPP(+)-lesioned rat brain.

S M Liang1, C M Liang, C C Chiueh.   

Abstract

The tissue distribution of interleukin-2 (IL-2) in normal and 1-methyl-4-phenyl-pyridinium (MPP+)-lesioned brains of rats was investigated. Intrastriatal administration of MPP+ caused visible damage in the vicinity of the injected region two weeks after injection. Autoradiography of the tissue section with anti-IL-2 antibodies plus trace amounts of radiolabeled IL-2 showed that the antibodies treatment elicited a selective radiolabeling of the brain tissues localized at the MPP(+)-lesioned region but not at normal cryo-sliced sections. Addition of radiolabeled IL-2 alone or normal rabbit immunoglobulins did not show any labeling effect. These autoradiographic imaging results suggest that there is an accumulation of cells bearing IL-2-like molecules at the MPP(+)-induced lesion sites.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2610695     DOI: 10.1016/0006-291x(89)92746-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Identification of an interleukin 2-like substance as a factor cytotoxic to oligodendrocytes and associated with central nervous system regeneration.

Authors:  S Eitan; R Zisling; A Cohen; M Belkin; D L Hirschberg; M Lotan; M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain. Short communication.

Authors:  M Mogi; M Harada; T Kondo; P Riederer; T Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  [125I]CGP 42112 reveals a non-angiotensin II binding site in 1-methyl-4-phenylpyridine (MPP+)-induced brain injury.

Authors:  M Viswanathan; A M de Oliveira; R M Wu; C C Chiueh; J M Saavedra
Journal:  Cell Mol Neurobiol       Date:  1994-02       Impact factor: 5.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.